All Stories

  1. Pathways Connecting Late-Life Depression and Dementia
  2. Taking Off the Blinders: The Critical Phase of Suicidality Doesn’t End With Discharge From Inpatient Treatment
  3. Molecular and cellular dissection of NMDA receptor subtypes as antidepressant targets
  4. Cytokine serum levels remain unchanged during lithium augmentation of antidepressants in major depression
  5. Aggression and violence in psychiatric hospitals with and without open door policies: A 15-year naturalistic observational study
  6. Green tea effects on cognition, mood and human brain function: A systematic review
  7. Modulation of HPA axis response to social stress in schizophrenia by childhood trauma
  8. Age-related brain structural alterations as an intermediate phenotype of psychosis
  9. The impact of gut hormones on the neural circuit of appetite and satiety: A systematic review
  10. Wide range of age of onset and low referral rates to psychiatry in a large cohort of acne excoriée at a Swiss tertiary hospital
  11. Modulation of HPA axis response to social stress in schizophrenia by childhood trauma
  12. Ghrelin Serum Concentrations Are Associated with Treatment Response During Lithium Augmentation of Antidepressants
  13. Einfluss einer „Offenen-Tür-Politik“ auf die Stationsatmosphäre: Auswirkungen auf die Behandlungsqualität
  14. Perceived Dangerousness as Related to Psychiatric Symptoms and Psychiatric Service Use – a Vignette Based Representative Population Survey
  15. Experimentally induced psychosocial stress in schizophrenia spectrum disorders: A systematic review
  16. The association of psychopathology with concurrent level of functioning and subjective well-being in persons with schizophrenia spectrum disorders
  17. Modulation of the activity of N-methyl-D-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13)
  18. Effects of assisted outpatient treatment and health care services on psychotic symptoms
  19. Alcohol consumption and use of health care services in people with severe mental illness and stressful childhood experiences
  20. Depression in the Context of Medical Disorders: New Pharmacological Pathways Revisited
  21. Effect of Door-Locking Policy on Inpatient Treatment of Substance Use and Dual Disorders
  22. Puberty marks major changes in the hippocampal and cortical c-Fos activation pattern induced by NMDA receptor antagonists
  23. Open Wards in Psychiatric Clinics and Compulsory Psychiatric Admissions
  24. Arbitrary classification of hospital policy regarding open and locked doors – Authors' reply
  25. Dysfunctional insular connectivity during reward prediction in patients with first-episode psychosis
  26. Stigmatization of psychiatric symptoms and psychiatric service use: a vignette-based representative population survey
  27. The antidepressant effect of ketamine: Mediated by AMPA receptors?
  28. Über die Reduktion von Zwangsmaßnahmen durch eine „offene Türpolitik“
  29. Leptin serum concentrations are associated with weight gain during lithium augmentation
  30. Suicide risk and absconding in psychiatric hospitals with and without open door policies: a 15 year, observational study
  31. Counter striking psychosis: Commercial video games as potential treatment in schizophrenia? A systematic review of neuroimaging studies
  32. Structural Network Disorganization in Subjects at Clinical High Risk for Psychosis
  33. Increased superior frontal gyrus activation during working memory processing in psychosis: Significant relation to cumulative antipsychotic medication and to negative symptoms
  34. Vergleichende Betrachtung von Aggressivität, Zwangsmedikation und Entweichungsraten zwischen offener und geschlossener Türpolitik auf einer Akutstation
  35. Evaluation of medication-assisted treatment of opioid dependence—The physicians’ perspective
  36. Microglia Activation and Schizophrenia: Lessons From the Effects of Minocycline on Postnatal Neurogenesis, Neuronal Survival and Synaptic Pruning
  37. 1,25(OH)2D3 dependent overt hyperactivity phenotype in klotho-hypomorphic mice
  38. Aktuelle psychiatrische Versorgung in der Schweiz
  39. Role of Serum Brain Derived Neurotrophic Factor and Central N-Acetylaspartate for Clinical Response under Antidepressive Pharmacotherapy
  40. Depression and Obesity
  41. Stability of trauma-related symptoms during acute substance use treatment
  42. Modulation of motivational salience processing during the early stages of psychosis
  43. Sex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-β or hyperphosphorylated tau protein
  44. What We Can Learn From Animal Behavior
  45. Behavioral Testing of Mice Concerning Anxiety and Depression
  46. Phosphoinositide-Dependent Protein Kinase 1 (PDK1)
  47. From Animal Behavior to Human Health
  48. Approaching a network connectivity-driven classification of the psychosis continuum: a selective review and suggestions for future research
  49. Classifying individuals at high-risk for psychosis based on functional brain activity during working memory processing
  50. Nutritional Aspects of Depression
  51. Hippocampal volume correlates with attenuated negative psychotic symptoms irrespective of antidepressant medication
  52. Reduced volume of the nucleus accumbens in heroin addiction
  53. Impact of Lithium Treatment on FGF-23 Serum Concentrations in Depressive Patients
  54. Beyond Watches and Chocolate—Global Mental Health Elective in Switzerland
  55. Declining transition rates to psychosis: The role of diagnostic spectra and symptom overlaps in individuals with attenuated psychosis syndrome
  56. Acute Effects of Heroin on Negative Emotional Processing: Relation of Amygdala Activity and Stress-Related Responses
  57. Cenesthopathy in adolescence: An appraisal of diagnostic overlaps along the anxiety–hypochondriasis–psychosis spectrum
  58. Reduction of seclusion on a hospital-wide level: Successful implementation of a less restrictive policy
  59. Effects of Cannabis on Impulsivity: A Systematic Review of Neuroimaging Findings
  60. Poster #T220 TRANSITION AND PSYCHOSIS RELATED HEMODYNAMIC CORRELATES OF MOTIVATIONAL SALIENCE PROCESSING
  61. Stressful childhood experiences and health outcomes in sexual minority populations: a systematic review
  62. Schmidt a psychosis
  63. The attenuated psychosis syndrome in DSM-5
  64. Brain-Derived Neurotrophic Factor Serum Concentrations in Acute Depressive Patients Increase During Lithium Augmentation of Antidepressants
  65. Sicherheit, therapeutischer Halt und Patientenzusammenhalt auf geschlossenen, neu geöffneten und offenen psychiatrischen Stationen
  66. Animal-Assisted Therapy and Agitation and Depression in Nursing Home Residents with Dementia: A Matched Case–Control Trial
  67. D.11 - THE ACID SPHINGOMYELINASE/CERAMIDE SYSTEM AS A NEW PATHWAY FOR ANTI-DEPRESSANT ACTION
  68. Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs
  69. Call for Papers: “Animal Behavior and Mental Illness”
  70. Impact of Vitamin D Receptor VDR rs2228570 Polymorphism in Oldest Old
  71. Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
  72. Serum Brain-Derived Neurotrophic Factor and Nerve Growth Factor Concentrations Change after Alcohol Withdrawal: Preliminary Data of a Case-Control Comparison
  73. Hippocampal volume in subjects at high risk of psychosis: A longitudinal MRI study
  74. Resting State Abnormalities in Psychosis Compared to Acute Cannabinoids and Opioids Challenges: A Systematic Review of Functional Imaging Studies
  75. Reduced Brain-Derived Neurotrophic Factor Serum Concentrations in Acute Schizophrenic Patients Increase During Antipsychotic Treatment
  76. COMT Val108/158Met genotype modulates human sensory gating
  77. Exploring the relationship between vitamin D and basic personality traits
  78. Do locked doors in psychiatric hospitals prevent patients from absconding?
  79. Significance of SGK1 in the regulation of neuronal function
  80. Reduced anxiety during dog assisted interviews in acute schizophrenic patients
  81. Impairment of Phosphatidylinositol 3-Kinase Signaling in Schizophrenia: State or Trait?
  82. Konsiliarpsychiatrie
  83. Hyperactivity and Enhanced Curiosity of Mice Expressing PKB/SGK-resistant Glycogen Synthase Kinase-3 (GSK-3)
  84. Met carriers of BDNF Val66Met genotype show increased N-acetylaspartate concentration in the anterior cingulate cortex
  85. Vocal Tics Associated With Ziprasidone
  86. Dog-assisted intervention significantly reduces anxiety in hospitalized patients with major depression
  87. PIP5K2A-dependent regulation of excitatory amino acid transporter EAAT3
  88. Regulation of the Na+-coupled glutamate transporter EAAT3 by PIKfyve
  89. A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels
  90. Acute prefrontal cortex transcranial magnetic stimulation in healthy volunteers: No effects on brain-derived neurotrophic factor (BDNF) concentrations in serum
  91. Correlation Between Serum Brain-Derived Neurotrophic Factor Level and An In Vivo Marker of Cortical Integrity
  92. Serum neurotrophins—A study on the time course and influencing factors in a large old age sample
  93. Gender-Dependent Association of the Functional Catechol-O-Methyltransferase Val158Met Genotype with Sensation Seeking Personality Trait
  94. Motor Cortex Excitability After Vagus Nerve Stimulation in Major Depression
  95. Gender-Dependent Association of the Functional Catechol-O-Methyltransferase Val158Met Genotype with Sensation Seeking Personality Trait
  96. Abnormal Hippocampal Neurochemistry in Smokers
  97. Molecular Mechanisms of Schizophrenia
  98. Thyrotropin Serum Concentrations in Healthy Volunteers Are Associated with Depression-Related Personality Traits
  99. Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking
  100. Charles Bonnet Syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors
  101. Brain-derived neurotrophic factor serum concentrations in depressive patients during vagus nerve stimulation and repetitive transcranial magnetic stimulation
  102. Evidence for Impaired Cortical Inhibition in Patients with Unipolar Major Depression
  103. Reduced locomotion in the serum and glucocorticoid inducible kinase 3 knock out mouse
  104. Motor Cortical Excitability in Depressive Patients After Electroconvulsive Therapy and Repetitive Transcranial Magnetic Stimulation
  105. Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex and cortical excitability in patients with major depressive disorder
  106. Impact of Levodopa on Reduced Nerve Growth Factor Levels in Patients With Parkinson Disease
  107. Reply: Indicators of Central Serotonergic Activity: How ‘Specific’ is Neurotransmission?
  108. Decreased intestinal glucose transport in the sgk3-knockout mouse
  109. Association of human hippocampal neurochemistry, serotonin transporter genetic variation, and anxiety
  110. Association of BDNF Serum Concentrations with Central Serotonergic Activity: Evidence from Auditory Signal Processing
  111. Brain-derived neurotrophic factor serum concentrations are increased in drug-naïve schizophrenic patients with chronic cannabis abuse and multiple substance abuse
  112. Impact of aerobic training on immune-endocrine parameters, neurotrophic factors, quality of life and coordinative function in multiple sclerosis
  113. GABAergic modulation of DC stimulation-induced motor cortex excitability shifts in humans
  114. Measurement of Nerve Growth Factor Serum Concentration in a Psychologically Stressful Situation in Men
  115. Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior
  116. BDNF Serum Concentrations in Healthy Volunteers are Associated with Depression-Related Personality Traits
  117. No Association of a Functional Polymorphism in the Serotonin Transporter Gene Promoter and Anxiety-Related Personality Traits
  118. Chronic Cannabis Abuse Raises Nerve Growth Factor Serum Concentrations in Drug-Naive Schizophrenic Patients
  119. Effects of different kinds of acute stress on nerve growth factor content in rat brain
  120. Emotional instability but intact spatial cognition in adenosine receptor 1 knock out mice
  121. Nerve growth factor serum concentrations in healthy human volunteers: physiological variance and stability
  122. Basal serum levels and reactivity of nerve growth factor and brain-derived neurotrophic factor to standardized acute exercise in multiple sclerosis and controls
  123. Chapter 43 Motorcortical excitability after electroconvulsive therapy in patients with major depressive disorder
  124. Nerve Growth Factor and Smoking Cessation